CompoAtlas

Akita Rose Sunscreen SPF 40

Natural health product licensed in Canada

Other names
Akita Écran solaire à la rose FPS 40
Licence holder
Akita RoseWater Inc.
NPN or DIN-HM
80151353
Status
Active licence
Licence date
1 October 2026
Revision date
Not provided
Form
Lotion
Route of administration
Topique
Application type
Officinale

Oral dose analysis does not apply without an established exclusively oral route.

Composition

Medicinal ingredient and sourcePer dosage unit, according to the source
Dioxyde de titane

Source : Dioxyde de titane

19 % (p/p)

Non-medicinal ingredients

Stéarate de glycéryle, Alcool cétéarylique, Cire d'abeille, blanche, Cétéareth-20, Extrait de graine de Citrus grandis, Huile de fleurs de Rosa damascena, Huile de graine de Sesamum indicum (Sésame), Eau de fleur de Rosa Damascena, Huile de fruits d'Olea europaea (Olivier), Huile de Prunus amygdalus dulcis (Amande douce), Huile de graine de Corylus Avellana (Noisette)

PopulationAgeQuantity per servingFrequency
Nourrissonsminimum: 6 months ; maximum: 12 monthsNot specifiedNot specified
Enfantsminimum: 1 year ; maximum: 11 yearsNot specifiedNot specified
Adultesminimum: 18 yearsNot specifiedNot specified
Adolescentesminimum: 12 years ; maximum: 17 yearsNot specifiedNot specified

Uses authorised in Canada

Text supplied in English because no French text is available.

Broad spectrum. Helps prevent sunburn. If used as directed with other sun protection measures [see Directions (for Use)], decreases the risk of skin cancer and early skin aging caused by the sun. Sun Protection Factor 40/SPF 40. Sunscreen. UVA/UVB protection.

A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.

Warnings in Canada

No French warning text available in the imported data.

Warnings are available in English on the official record.

Source

Official Health Canada record, licence 80151353

Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.

Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)

Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)

The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Enter to analyse, Shift+Enter for a new line